1. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications
   Sharmila Shankar et al, 2004, Drug Resistance Updates CrossRef
2. Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis
   Sharmila Shankar et al, 2008, Clinical Cancer Research CrossRef
3. On the TRAIL Toward Death Receptor–Based Cancer Therapeutics
   Thomas F. Gajewski, 2007, Journal of Clinical Oncology CrossRef
4. Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms
   Sharmila Shankar et al, 2008, Molecular Cancer Therapeutics CrossRef
5. High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m–labeled anti-DR5 antibody in breast tumor xenografts
   Hyunki Kim et al, 2007, Molecular Cancer Therapeutics CrossRef
6. Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
   Avi Ashkenazi et al, 2008, Journal of Clinical Oncology CrossRef